May 11, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Cindy Polynice
Re: Harpoon Therapeutics, Inc.
Registration Statement on Form S-3, as amended
File No. 333-271400
Acceleration Request
Requested Date: May 15, 2023
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3, as amended (File No. 333-271400) (the “Registration Statement”) to become effective on Monday, May 15, 2023 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes each of Courtney M.W. Tygesson and Marina Remennik of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Marina Remennik at (650) 843-5124.
| Very truly yours, | ||
| HARPOON THERAPEUTICS, INC. | ||
| By: | /s/ Julie Eastland | |
| Julie Eastland | ||
| President and Chief Executive Officer | ||
| cc: | Courtney M.W. Tygesson, Cooley LLP |
Marina Remennik, Cooley LLP
